Cancer Research UK launches outpatients trial

Cancer Research UK has announced that it has initiated a clinical trial that will allow patients taking part to stay at home and take the medication in tablet form.

Clinical trials are vital in the development of new cancer treatment, but are often hindered by the commitment issues, as patients usually need to stay in hospitals for long periods of time.

"It's great news that we're able to run a trial of this exciting drug as a tablet which will be a much more convenient and comfortable way to receive the treatment," said professor Ruth Plummer, the trial's chief investigator.

She explained that making the drug available in tablet form allowed participants to regain some semblance of normality, as they would not be hooked up to a drip.

Patients will test the effectiveness of Rucaparib, a PARP inhibitor, which has so far displayed promising results when used to treat breast cancer.

Scientists funded by the charity recently discovered that oestrogen concentrations are linked to the likelihood of a breast cancer relapse.

Comment on this page »


Latest news

Chelsea and Westminster named the best place to work in the NHS for 2015

Nuffield Health opens doors of new Cambridge Hospital

Nuffield Health plans to open state-of-the-art diagnostic suite

Cancer Research UK launches outpatients trial
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information